APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pemetrexed Disodium Lyophilized Powder

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pemetrexed Disodium Lyophilized Powder Market Outlook and Growth Opportunities 2026

Report ID 174023260422 December 2025217 pages

Choose your research edition.

Industry ResearchPemetrexed Disodium Lyophilized Powder Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Pemetrexed Disodium Lyophilized Powder Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Pemetrexed Disodium Lyophilized Powder Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pemetrexed Disodium Lyophilized Powder Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Pemetrexed Disodium Lyophilized Powder Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

The global Pemetrexed Disodium Lyophilized Powder market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pemetrexed Disodium Lyophilized Powder is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pemetrexed Disodium Lyophilized Powder is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pemetrexed Disodium Lyophilized Powder is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pemetrexed Disodium Lyophilized Powder market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pemetrexed Disodium Lyophilized Powder market include Yangtze River Pharmaceutical Group, Jiangsu Simcere Pharmaceutical, Suzhou Thery Pharmaceutical, Suzhou Erye Pharmaceutical, Sichuan Huiyu Pharmaceutical, Shanghai Chemo Wanbang Biopharma, Zhendong Group, Sandoz and Jiangsu Hansoh Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pemetrexed Disodium Lyophilized Powder market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pemetrexed Disodium Lyophilized Powder and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pemetrexed Disodium Lyophilized Powder sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pemetrexed Disodium Lyophilized Powder market size, projected growth trends, production technologies, key applications, and end-use industries.

Pemetrexed Disodium Lyophilized Powder Segment by Company

Yangtze River Pharmaceutical Group

Jiangsu Simcere Pharmaceutical

Suzhou Thery Pharmaceutical

Suzhou Erye Pharmaceutical

Sichuan Huiyu Pharmaceutical

Shanghai Chemo Wanbang Biopharma

Zhendong Group

Sandoz

Jiangsu Hansoh Pharmaceutical

Nanjing Pharmaceutical Factory

Lianyungang Jaripharm Pharmaceutical

Lilly

Qilu Pharmaceutical

Jiangsu Aosaikang Pharmaceutical

Kelun Pharmaceutical

Hainan Jinrui Pharmaceutical

Fresenius Kabi

Dezhou Deyao Pharmaceutical

Beijing Xiehe Pharmaceutical

Baxter

Zydus Lifesciences

Waverley Pharma

Pfizer (Hospira)

Nang Kuang Pharmaceutical

Eugia Pharma

Dr. Reddy's Laboratories

Biocon

APOTEX

Amneal Pharmaceuticals

Accord Healthcare

Pemetrexed Disodium Lyophilized Powder Segment by Type

100mg/Pcs

500mg/Pcs

Pemetrexed Disodium Lyophilized Powder Segment by Application

Hospitals

Clinics

Others

Pemetrexed Disodium Lyophilized Powder Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pemetrexed Disodium Lyophilized Powder status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Pemetrexed Disodium Lyophilized Powder market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pemetrexed Disodium Lyophilized Powder significant trends, drivers, influence factors in global and regions.

6. To analyze Pemetrexed Disodium Lyophilized Powder competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pemetrexed Disodium Lyophilized Powder market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pemetrexed Disodium Lyophilized Powder and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pemetrexed Disodium Lyophilized Powder.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pemetrexed Disodium Lyophilized Powder market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pemetrexed Disodium Lyophilized Powder industry.

Chapter 3: Detailed analysis of Pemetrexed Disodium Lyophilized Powder manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Pemetrexed Disodium Lyophilized Powder in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Pemetrexed Disodium Lyophilized Powder in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pemetrexed Disodium Lyophilized Powder Industry Trends Table 2. Pemetrexed Disodium Lyophilized Powder Industry Drivers Table 3. Pemetrexed Disodium Lyophilized Powder Industry Opportunities and Challenges Table 4. Pemetrexed Disodium Lyophilized Powder Industry Restraints Table 5. Global Pemetrexed Disodium Lyophilized Powder Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pemetrexed Disodium Lyophilized Powder Revenue Share by Company (2021-2026) Table 7. Global Pemetrexed Disodium Lyophilized Powder Sales Volume by Company (k units) & (2021-2026) Table 8. Global Pemetrexed Disodium Lyophilized Powder Sales Volume Share by Company (2021-2026) Table 9. Global Pemetrexed Disodium Lyophilized Powder Average Price (US$/unit) of Company (2021-2026) Table 10. Global Pemetrexed Disodium Lyophilized Powder Company Ranking, (2024-2026) & (USD Million) Table 11. Global Pemetrexed Disodium Lyophilized Powder Key Company Manufacturing Base & Headquarters Table 12. Global Pemetrexed Disodium Lyophilized Powder Company, Product Type & Application Table 13. Global Pemetrexed Disodium Lyophilized Powder Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Pemetrexed Disodium Lyophilized Powder by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 100mg/Pcs Table 18. Significant Companies of 500mg/Pcs Table 19. Global Pemetrexed Disodium Lyophilized Powder Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Pemetrexed Disodium Lyophilized Powder Sales Volume by Type (2021-2026) & (k units) Table 21. Global Pemetrexed Disodium Lyophilized Powder Sales Volume by Type (2027-2032) & (k units) Table 22. Global Pemetrexed Disodium Lyophilized Powder Sales Volume Share by Type (2021-2026) Table 23. Global Pemetrexed Disodium Lyophilized Powder Sales Volume Share by Type (2027-2032) Table 24. Global Pemetrexed Disodium Lyophilized Powder Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Pemetrexed Disodium Lyophilized Powder Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Pemetrexed Disodium Lyophilized Powder Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type (2021-2026) Table 28. Global Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospitals Table 30. Significant Companies of Clinics Table 31. Significant Companies of Others Table 32. Global Pemetrexed Disodium Lyophilized Powder Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Pemetrexed Disodium Lyophilized Powder Sales Volume by Application (2021-2026) & (k units) Table 34. Global Pemetrexed Disodium Lyophilized Powder Sales Volume by Application (2027-2032) & (k units) Table 35. Global Pemetrexed Disodium Lyophilized Powder Sales Volume Share by Application (2021-2026) Table 36. Global Pemetrexed Disodium Lyophilized Powder Sales Volume Share by Application (2027-2032) Table 37. Global Pemetrexed Disodium Lyophilized Powder Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Pemetrexed Disodium Lyophilized Powder Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Pemetrexed Disodium Lyophilized Powder Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application (2021-2026) Table 41. Global Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application (2027-2032) Table 42. Global Pemetrexed Disodium Lyophilized Powder Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Pemetrexed Disodium Lyophilized Powder Sales by Region (2021-2026) & (k units) Table 44. Global Pemetrexed Disodium Lyophilized Powder Sales Market Share by Region (2021-2026) Table 45. Global Pemetrexed Disodium Lyophilized Powder Sales by Region (2027-2032) & (k units) Table 46. Global Pemetrexed Disodium Lyophilized Powder Sales Market Share by Region (2027-2032) Table 47. Global Pemetrexed Disodium Lyophilized Powder Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Pemetrexed Disodium Lyophilized Powder Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Pemetrexed Disodium Lyophilized Powder Sales Value Share by Region (2021-2026) Table 50. Global Pemetrexed Disodium Lyophilized Powder Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Pemetrexed Disodium Lyophilized Powder Sales Value Share by Region (2027-2032) Table 52. Global Pemetrexed Disodium Lyophilized Powder Market Average Price (US$/unit) by Region (2021-2026) Table 53. Global Pemetrexed Disodium Lyophilized Powder Market Average Price (US$/unit) by Region (2027-2032) Table 54. Global Pemetrexed Disodium Lyophilized Powder Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Pemetrexed Disodium Lyophilized Powder Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Pemetrexed Disodium Lyophilized Powder Sales by Country (2021-2026) & (k units) Table 57. Global Pemetrexed Disodium Lyophilized Powder Sales Market Share by Country (2021-2026) Table 58. Global Pemetrexed Disodium Lyophilized Powder Sales by Country (2027-2032) & (k units) Table 59. Global Pemetrexed Disodium Lyophilized Powder Sales Market Share by Country (2027-2032) Table 60. Global Pemetrexed Disodium Lyophilized Powder Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Pemetrexed Disodium Lyophilized Powder Sales Value Market Share by Country (2021-2026) Table 62. Global Pemetrexed Disodium Lyophilized Powder Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Pemetrexed Disodium Lyophilized Powder Sales Value Market Share by Country (2027-2032) Table 64. Yangtze River Pharmaceutical Group Company Information Table 65. Yangtze River Pharmaceutical Group Business Overview Table 66. Yangtze River Pharmaceutical Group Pemetrexed Disodium Lyophilized Powder Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Yangtze River Pharmaceutical Group Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 68. Yangtze River Pharmaceutical Group Recent Development Table 69. Jiangsu Simcere Pharmaceutical Company Information Table 70. Jiangsu Simcere Pharmaceutical Business Overview Table 71. Jiangsu Simcere Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Jiangsu Simcere Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 73. Jiangsu Simcere Pharmaceutical Recent Development Table 74. Suzhou Thery Pharmaceutical Company Information Table 75. Suzhou Thery Pharmaceutical Business Overview Table 76. Suzhou Thery Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Suzhou Thery Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 78. Suzhou Thery Pharmaceutical Recent Development Table 79. Suzhou Erye Pharmaceutical Company Information Table 80. Suzhou Erye Pharmaceutical Business Overview Table 81. Suzhou Erye Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Suzhou Erye Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 83. Suzhou Erye Pharmaceutical Recent Development Table 84. Sichuan Huiyu Pharmaceutical Company Information Table 85. Sichuan Huiyu Pharmaceutical Business Overview Table 86. Sichuan Huiyu Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Sichuan Huiyu Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 88. Sichuan Huiyu Pharmaceutical Recent Development Table 89. Shanghai Chemo Wanbang Biopharma Company Information Table 90. Shanghai Chemo Wanbang Biopharma Business Overview Table 91. Shanghai Chemo Wanbang Biopharma Pemetrexed Disodium Lyophilized Powder Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Shanghai Chemo Wanbang Biopharma Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 93. Shanghai Chemo Wanbang Biopharma Recent Development Table 94. Zhendong Group Company Information Table 95. Zhendong Group Business Overview Table 96. Zhendong Group Pemetrexed Disodium Lyophilized Powder Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Zhendong Group Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 98. Zhendong Group Recent Development Table 99. Sandoz Company Information Table 100. Sandoz Business Overview Table 101. Sandoz Pemetrexed Disodium Lyophilized Powder Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Sandoz Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 103. Sandoz Recent Development Table 104. Jiangsu Hansoh Pharmaceutical Company Information Table 105. Jiangsu Hansoh Pharmaceutical Business Overview Table 106. Jiangsu Hansoh Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Jiangsu Hansoh Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 108. Jiangsu Hansoh Pharmaceutical Recent Development Table 109. Nanjing Pharmaceutical Factory Company Information Table 110. Nanjing Pharmaceutical Factory Business Overview Table 111. Nanjing Pharmaceutical Factory Pemetrexed Disodium Lyophilized Powder Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Nanjing Pharmaceutical Factory Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 113. Nanjing Pharmaceutical Factory Recent Development Table 114. Lianyungang Jaripharm Pharmaceutical Company Information Table 115. Lianyungang Jaripharm Pharmaceutical Business Overview Table 116. Lianyungang Jaripharm Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. Lianyungang Jaripharm Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 118. Lianyungang Jaripharm Pharmaceutical Recent Development Table 119. Lilly Company Information Table 120. Lilly Business Overview Table 121. Lilly Pemetrexed Disodium Lyophilized Powder Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 122. Lilly Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 123. Lilly Recent Development Table 124. Qilu Pharmaceutical Company Information Table 125. Qilu Pharmaceutical Business Overview Table 126. Qilu Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 127. Qilu Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 128. Qilu Pharmaceutical Recent Development Table 129. Jiangsu Aosaikang Pharmaceutical Company Information Table 130. Jiangsu Aosaikang Pharmaceutical Business Overview Table 131. Jiangsu Aosaikang Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 132. Jiangsu Aosaikang Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 133. Jiangsu Aosaikang Pharmaceutical Recent Development Table 134. Kelun Pharmaceutical Company Information Table 135. Kelun Pharmaceutical Business Overview Table 136. Kelun Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 137. Kelun Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 138. Kelun Pharmaceutical Recent Development Table 139. Hainan Jinrui Pharmaceutical Company Information Table 140. Hainan Jinrui Pharmaceutical Business Overview Table 141. Hainan Jinrui Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 142. Hainan Jinrui Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 143. Hainan Jinrui Pharmaceutical Recent Development Table 144. Fresenius Kabi Company Information Table 145. Fresenius Kabi Business Overview Table 146. Fresenius Kabi Pemetrexed Disodium Lyophilized Powder Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 147. Fresenius Kabi Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 148. Fresenius Kabi Recent Development Table 149. Dezhou Deyao Pharmaceutical Company Information Table 150. Dezhou Deyao Pharmaceutical Business Overview Table 151. Dezhou Deyao Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 152. Dezhou Deyao Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 153. Dezhou Deyao Pharmaceutical Recent Development Table 154. Beijing Xiehe Pharmaceutical Company Information Table 155. Beijing Xiehe Pharmaceutical Business Overview Table 156. Beijing Xiehe Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 157. Beijing Xiehe Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 158. Beijing Xiehe Pharmaceutical Recent Development Table 159. Baxter Company Information Table 160. Baxter Business Overview Table 161. Baxter Pemetrexed Disodium Lyophilized Powder Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 162. Baxter Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 163. Baxter Recent Development Table 164. Zydus Lifesciences Company Information Table 165. Zydus Lifesciences Business Overview Table 166. Zydus Lifesciences Pemetrexed Disodium Lyophilized Powder Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 167. Zydus Lifesciences Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 168. Zydus Lifesciences Recent Development Table 169. Waverley Pharma Company Information Table 170. Waverley Pharma Business Overview Table 171. Waverley Pharma Pemetrexed Disodium Lyophilized Powder Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 172. Waverley Pharma Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 173. Waverley Pharma Recent Development Table 174. Pfizer (Hospira) Company Information Table 175. Pfizer (Hospira) Business Overview Table 176. Pfizer (Hospira) Pemetrexed Disodium Lyophilized Powder Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 177. Pfizer (Hospira) Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 178. Pfizer (Hospira) Recent Development Table 179. Nang Kuang Pharmaceutical Company Information Table 180. Nang Kuang Pharmaceutical Business Overview Table 181. Nang Kuang Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 182. Nang Kuang Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 183. Nang Kuang Pharmaceutical Recent Development Table 184. Eugia Pharma Company Information Table 185. Eugia Pharma Business Overview Table 186. Eugia Pharma Pemetrexed Disodium Lyophilized Powder Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 187. Eugia Pharma Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 188. Eugia Pharma Recent Development Table 189. Dr. Reddy's Laboratories Company Information Table 190. Dr. Reddy's Laboratories Business Overview Table 191. Dr. Reddy's Laboratories Pemetrexed Disodium Lyophilized Powder Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 192. Dr. Reddy's Laboratories Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 193. Dr. Reddy's Laboratories Recent Development Table 194. Biocon Company Information Table 195. Biocon Business Overview Table 196. Biocon Pemetrexed Disodium Lyophilized Powder Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 197. Biocon Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 198. Biocon Recent Development Table 199. APOTEX Company Information Table 200. APOTEX Business Overview Table 201. APOTEX Pemetrexed Disodium Lyophilized Powder Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 202. APOTEX Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 203. APOTEX Recent Development Table 204. Amneal Pharmaceuticals Company Information Table 205. Amneal Pharmaceuticals Business Overview Table 206. Amneal Pharmaceuticals Pemetrexed Disodium Lyophilized Powder Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 207. Amneal Pharmaceuticals Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 208. Amneal Pharmaceuticals Recent Development Table 209. Accord Healthcare Company Information Table 210. Accord Healthcare Business Overview Table 211. Accord Healthcare Pemetrexed Disodium Lyophilized Powder Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 212. Accord Healthcare Pemetrexed Disodium Lyophilized Powder Product Portfolio Table 213. Accord Healthcare Recent Development Table 214. Key Raw Materials Table 215. Raw Materials Key Suppliers Table 216. Pemetrexed Disodium Lyophilized Powder Distributors List Table 217. Pemetrexed Disodium Lyophilized Powder Customers List Table 218. Research Programs/Design for This Report Table 219. Authors List of This Report Table 220. Secondary Sources Table 221. Primary Sources List of Figures Figure 1. Pemetrexed Disodium Lyophilized Powder Product Image Figure 2. Global Pemetrexed Disodium Lyophilized Powder Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pemetrexed Disodium Lyophilized Powder Sales Value (2021-2032) & (US$ Million) Figure 4. Global Pemetrexed Disodium Lyophilized Powder Sales (2021-2032) & (k units) Figure 5. Global Pemetrexed Disodium Lyophilized Powder Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Pemetrexed Disodium Lyophilized Powder Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 100mg/Pcs Image Figure 10. 500mg/Pcs Image Figure 11. Global Pemetrexed Disodium Lyophilized Powder Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Pemetrexed Disodium Lyophilized Powder Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Pemetrexed Disodium Lyophilized Powder Sales Volume Share by Type (2021-2032) Figure 14. Global Pemetrexed Disodium Lyophilized Powder Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Pemetrexed Disodium Lyophilized Powder Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type (2021-2032) Figure 17. Hospitals Image Figure 18. Clinics Image Figure 19. Others Image Figure 20. Global Pemetrexed Disodium Lyophilized Powder Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Pemetrexed Disodium Lyophilized Powder Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Pemetrexed Disodium Lyophilized Powder Sales Volume Share by Application (2021-2032) Figure 23. Global Pemetrexed Disodium Lyophilized Powder Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Pemetrexed Disodium Lyophilized Powder Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application (2021-2032) Figure 26. Global Pemetrexed Disodium Lyophilized Powder Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Pemetrexed Disodium Lyophilized Powder Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Pemetrexed Disodium Lyophilized Powder Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Pemetrexed Disodium Lyophilized Powder Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Pemetrexed Disodium Lyophilized Powder Sales Value (2021-2032) & (US$ Million) Figure 31. North America Pemetrexed Disodium Lyophilized Powder Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Pemetrexed Disodium Lyophilized Powder Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Pemetrexed Disodium Lyophilized Powder Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Pemetrexed Disodium Lyophilized Powder Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Pemetrexed Disodium Lyophilized Powder Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Pemetrexed Disodium Lyophilized Powder Sales Value (2021-2032) & (US$ Million) Figure 37. South America Pemetrexed Disodium Lyophilized Powder Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Pemetrexed Disodium Lyophilized Powder Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Pemetrexed Disodium Lyophilized Powder Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Pemetrexed Disodium L

Scope & coverage.

Types
  • 100mg/Pcs
  • 500mg/Pcs
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Yangtze River Pharmaceutical Group
  • Jiangsu Simcere Pharmaceutical
  • Suzhou Thery Pharmaceutical
  • Suzhou Erye Pharmaceutical
  • Sichuan Huiyu Pharmaceutical
  • Shanghai Chemo Wanbang Biopharma
  • Zhendong Group
  • Sandoz
  • Jiangsu Hansoh Pharmaceutical
  • Nanjing Pharmaceutical Factory
  • Lianyungang Jaripharm Pharmaceutical
  • Lilly
  • Qilu Pharmaceutical
  • Jiangsu Aosaikang Pharmaceutical
  • Kelun Pharmaceutical
  • Hainan Jinrui Pharmaceutical
  • Fresenius Kabi
  • Dezhou Deyao Pharmaceutical
  • Beijing Xiehe Pharmaceutical
  • Baxter
  • Zydus Lifesciences
  • Waverley Pharma
  • Pfizer (Hospira)
  • Nang Kuang Pharmaceutical
  • Eugia Pharma
  • Dr. Reddy's Laboratories
  • Biocon
  • APOTEX
  • Amneal Pharmaceuticals
  • Accord Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pemetrexed Disodium Lyophilized Powder Sales Value (2021-2032)
  4. 1.2.2 Global Pemetrexed Disodium Lyophilized Powder Sales Volume (2021-2032)
  5. 1.2.3 Global Pemetrexed Disodium Lyophilized Powder Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Pemetrexed Disodium Lyophilized Powder Market Dynamics
  1. 2.1 Pemetrexed Disodium Lyophilized Powder Industry Trends
  2. 2.2 Pemetrexed Disodium Lyophilized Powder Industry Drivers
  3. 2.3 Pemetrexed Disodium Lyophilized Powder Industry Opportunities and Challenges
  4. 2.4 Pemetrexed Disodium Lyophilized Powder Industry Restraints
3 Pemetrexed Disodium Lyophilized Powder Market by Company
  1. 3.1 Global Pemetrexed Disodium Lyophilized Powder Company Revenue Ranking in 2025
  2. 3.2 Global Pemetrexed Disodium Lyophilized Powder Revenue by Company (2021-2026)
  3. 3.3 Global Pemetrexed Disodium Lyophilized Powder Sales Volume by Company (2021-2026)
  4. 3.4 Global Pemetrexed Disodium Lyophilized Powder Average Price by Company (2021-2026)
  5. 3.5 Global Pemetrexed Disodium Lyophilized Powder Company Ranking (2024-2026)
  6. 3.6 Global Pemetrexed Disodium Lyophilized Powder Company Manufacturing Base and Headquarters
  7. 3.7 Global Pemetrexed Disodium Lyophilized Powder Company Product Type and Application
  8. 3.8 Global Pemetrexed Disodium Lyophilized Powder Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Pemetrexed Disodium Lyophilized Powder Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Pemetrexed Disodium Lyophilized Powder Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Pemetrexed Disodium Lyophilized Powder Market by Type
  1. 4.1 Pemetrexed Disodium Lyophilized Powder Type Introduction
  2. 4.1.1 100mg/Pcs
  3. 4.1.2 500mg/Pcs
  4. 4.2 Global Pemetrexed Disodium Lyophilized Powder Sales Volume by Type
  5. 4.2.1 Global Pemetrexed Disodium Lyophilized Powder Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pemetrexed Disodium Lyophilized Powder Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Pemetrexed Disodium Lyophilized Powder Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Pemetrexed Disodium Lyophilized Powder Sales Value by Type
  9. 4.3.1 Global Pemetrexed Disodium Lyophilized Powder Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Pemetrexed Disodium Lyophilized Powder Sales Value by Type (2021-2032)
  11. 4.3.3 Global Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type (2021-2032)
5 Pemetrexed Disodium Lyophilized Powder Market by Application
  1. 5.1 Pemetrexed Disodium Lyophilized Powder Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Pemetrexed Disodium Lyophilized Powder Sales Volume by Application
  6. 5.2.1 Global Pemetrexed Disodium Lyophilized Powder Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pemetrexed Disodium Lyophilized Powder Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Pemetrexed Disodium Lyophilized Powder Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Pemetrexed Disodium Lyophilized Powder Sales Value by Application
  10. 5.3.1 Global Pemetrexed Disodium Lyophilized Powder Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Pemetrexed Disodium Lyophilized Powder Sales Value by Application (2021-2032)
  12. 5.3.3 Global Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application (2021-2032)
6 Pemetrexed Disodium Lyophilized Powder Regional Sales and Value Analysis
  1. 6.1 Global Pemetrexed Disodium Lyophilized Powder Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pemetrexed Disodium Lyophilized Powder Sales by Region (2021-2032)
  3. 6.2.1 Global Pemetrexed Disodium Lyophilized Powder Sales by Region: 2021-2026
  4. 6.2.2 Global Pemetrexed Disodium Lyophilized Powder Sales by Region (2027-2032)
  5. 6.3 Global Pemetrexed Disodium Lyophilized Powder Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Pemetrexed Disodium Lyophilized Powder Sales Value by Region (2021-2032)
  7. 6.4.1 Global Pemetrexed Disodium Lyophilized Powder Sales Value by Region: 2021-2026
  8. 6.4.2 Global Pemetrexed Disodium Lyophilized Powder Sales Value by Region (2027-2032)
  9. 6.5 Global Pemetrexed Disodium Lyophilized Powder Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Pemetrexed Disodium Lyophilized Powder Sales Value (2021-2032)
  12. 6.6.2 North America Pemetrexed Disodium Lyophilized Powder Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Pemetrexed Disodium Lyophilized Powder Sales Value (2021-2032)
  15. 6.7.2 Europe Pemetrexed Disodium Lyophilized Powder Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Pemetrexed Disodium Lyophilized Powder Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Pemetrexed Disodium Lyophilized Powder Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Pemetrexed Disodium Lyophilized Powder Sales Value (2021-2032)
  21. 6.9.2 South America Pemetrexed Disodium Lyophilized Powder Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Pemetrexed Disodium Lyophilized Powder Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Pemetrexed Disodium Lyophilized Powder Sales Value Share by Country, 2025 VS 2032
7 Pemetrexed Disodium Lyophilized Powder Country-level Sales and Value Analysis
  1. 7.1 Global Pemetrexed Disodium Lyophilized Powder Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pemetrexed Disodium Lyophilized Powder Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Pemetrexed Disodium Lyophilized Powder Sales by Country (2021-2032)
  4. 7.3.1 Global Pemetrexed Disodium Lyophilized Powder Sales by Country (2021-2026)
  5. 7.3.2 Global Pemetrexed Disodium Lyophilized Powder Sales by Country (2027-2032)
  6. 7.4 Global Pemetrexed Disodium Lyophilized Powder Sales Value by Country (2021-2032)
  7. 7.4.1 Global Pemetrexed Disodium Lyophilized Powder Sales Value by Country (2021-2026)
  8. 7.4.2 Global Pemetrexed Disodium Lyophilized Powder Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Pemetrexed Disodium Lyophilized Powder Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Pemetrexed Disodium Lyophilized Powder Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Pemetrexed Disodium Lyophilized Powder Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Yangtze River Pharmaceutical Group
  2. 8.1.1 Yangtze River Pharmaceutical Group Company Information
  3. 8.1.2 Yangtze River Pharmaceutical Group Business Overview
  4. 8.1.3 Yangtze River Pharmaceutical Group Pemetrexed Disodium Lyophilized Powder Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Yangtze River Pharmaceutical Group Pemetrexed Disodium Lyophilized Powder Product Portfolio
  6. 8.1.5 Yangtze River Pharmaceutical Group Recent Developments
  7. 8.2 Jiangsu Simcere Pharmaceutical
  8. 8.2.1 Jiangsu Simcere Pharmaceutical Company Information
  9. 8.2.2 Jiangsu Simcere Pharmaceutical Business Overview
  10. 8.2.3 Jiangsu Simcere Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Jiangsu Simcere Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
  12. 8.2.5 Jiangsu Simcere Pharmaceutical Recent Developments
  13. 8.3 Suzhou Thery Pharmaceutical
  14. 8.3.1 Suzhou Thery Pharmaceutical Company Information
  15. 8.3.2 Suzhou Thery Pharmaceutical Business Overview
  16. 8.3.3 Suzhou Thery Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Suzhou Thery Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
  18. 8.3.5 Suzhou Thery Pharmaceutical Recent Developments
  19. 8.4 Suzhou Erye Pharmaceutical
  20. 8.4.1 Suzhou Erye Pharmaceutical Company Information
  21. 8.4.2 Suzhou Erye Pharmaceutical Business Overview
  22. 8.4.3 Suzhou Erye Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Suzhou Erye Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
  24. 8.4.5 Suzhou Erye Pharmaceutical Recent Developments
  25. 8.5 Sichuan Huiyu Pharmaceutical
  26. 8.5.1 Sichuan Huiyu Pharmaceutical Company Information
  27. 8.5.2 Sichuan Huiyu Pharmaceutical Business Overview
  28. 8.5.3 Sichuan Huiyu Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Sichuan Huiyu Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
  30. 8.5.5 Sichuan Huiyu Pharmaceutical Recent Developments
  31. 8.6 Shanghai Chemo Wanbang Biopharma
  32. 8.6.1 Shanghai Chemo Wanbang Biopharma Company Information
  33. 8.6.2 Shanghai Chemo Wanbang Biopharma Business Overview
  34. 8.6.3 Shanghai Chemo Wanbang Biopharma Pemetrexed Disodium Lyophilized Powder Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Shanghai Chemo Wanbang Biopharma Pemetrexed Disodium Lyophilized Powder Product Portfolio
  36. 8.6.5 Shanghai Chemo Wanbang Biopharma Recent Developments
  37. 8.7 Zhendong Group
  38. 8.7.1 Zhendong Group Company Information
  39. 8.7.2 Zhendong Group Business Overview
  40. 8.7.3 Zhendong Group Pemetrexed Disodium Lyophilized Powder Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Zhendong Group Pemetrexed Disodium Lyophilized Powder Product Portfolio
  42. 8.7.5 Zhendong Group Recent Developments
  43. 8.8 Sandoz
  44. 8.8.1 Sandoz Company Information
  45. 8.8.2 Sandoz Business Overview
  46. 8.8.3 Sandoz Pemetrexed Disodium Lyophilized Powder Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Sandoz Pemetrexed Disodium Lyophilized Powder Product Portfolio
  48. 8.8.5 Sandoz Recent Developments
  49. 8.9 Jiangsu Hansoh Pharmaceutical
  50. 8.9.1 Jiangsu Hansoh Pharmaceutical Company Information
  51. 8.9.2 Jiangsu Hansoh Pharmaceutical Business Overview
  52. 8.9.3 Jiangsu Hansoh Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Jiangsu Hansoh Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
  54. 8.9.5 Jiangsu Hansoh Pharmaceutical Recent Developments
  55. 8.10 Nanjing Pharmaceutical Factory
  56. 8.10.1 Nanjing Pharmaceutical Factory Company Information
  57. 8.10.2 Nanjing Pharmaceutical Factory Business Overview
  58. 8.10.3 Nanjing Pharmaceutical Factory Pemetrexed Disodium Lyophilized Powder Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Nanjing Pharmaceutical Factory Pemetrexed Disodium Lyophilized Powder Product Portfolio
  60. 8.10.5 Nanjing Pharmaceutical Factory Recent Developments
  61. 8.11 Lianyungang Jaripharm Pharmaceutical
  62. 8.11.1 Lianyungang Jaripharm Pharmaceutical Company Information
  63. 8.11.2 Lianyungang Jaripharm Pharmaceutical Business Overview
  64. 8.11.3 Lianyungang Jaripharm Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Lianyungang Jaripharm Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
  66. 8.11.5 Lianyungang Jaripharm Pharmaceutical Recent Developments
  67. 8.12 Lilly
  68. 8.12.1 Lilly Company Information
  69. 8.12.2 Lilly Business Overview
  70. 8.12.3 Lilly Pemetrexed Disodium Lyophilized Powder Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Lilly Pemetrexed Disodium Lyophilized Powder Product Portfolio
  72. 8.12.5 Lilly Recent Developments
  73. 8.13 Qilu Pharmaceutical
  74. 8.13.1 Qilu Pharmaceutical Company Information
  75. 8.13.2 Qilu Pharmaceutical Business Overview
  76. 8.13.3 Qilu Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Qilu Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
  78. 8.13.5 Qilu Pharmaceutical Recent Developments
  79. 8.14 Jiangsu Aosaikang Pharmaceutical
  80. 8.14.1 Jiangsu Aosaikang Pharmaceutical Company Information
  81. 8.14.2 Jiangsu Aosaikang Pharmaceutical Business Overview
  82. 8.14.3 Jiangsu Aosaikang Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Jiangsu Aosaikang Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
  84. 8.14.5 Jiangsu Aosaikang Pharmaceutical Recent Developments
  85. 8.15 Kelun Pharmaceutical
  86. 8.15.1 Kelun Pharmaceutical Company Information
  87. 8.15.2 Kelun Pharmaceutical Business Overview
  88. 8.15.3 Kelun Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Kelun Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
  90. 8.15.5 Kelun Pharmaceutical Recent Developments
  91. 8.16 Hainan Jinrui Pharmaceutical
  92. 8.16.1 Hainan Jinrui Pharmaceutical Company Information
  93. 8.16.2 Hainan Jinrui Pharmaceutical Business Overview
  94. 8.16.3 Hainan Jinrui Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Hainan Jinrui Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
  96. 8.16.5 Hainan Jinrui Pharmaceutical Recent Developments
  97. 8.17 Fresenius Kabi
  98. 8.17.1 Fresenius Kabi Company Information
  99. 8.17.2 Fresenius Kabi Business Overview
  100. 8.17.3 Fresenius Kabi Pemetrexed Disodium Lyophilized Powder Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Fresenius Kabi Pemetrexed Disodium Lyophilized Powder Product Portfolio
  102. 8.17.5 Fresenius Kabi Recent Developments
  103. 8.18 Dezhou Deyao Pharmaceutical
  104. 8.18.1 Dezhou Deyao Pharmaceutical Company Information
  105. 8.18.2 Dezhou Deyao Pharmaceutical Business Overview
  106. 8.18.3 Dezhou Deyao Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Dezhou Deyao Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
  108. 8.18.5 Dezhou Deyao Pharmaceutical Recent Developments
  109. 8.19 Beijing Xiehe Pharmaceutical
  110. 8.19.1 Beijing Xiehe Pharmaceutical Company Information
  111. 8.19.2 Beijing Xiehe Pharmaceutical Business Overview
  112. 8.19.3 Beijing Xiehe Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Beijing Xiehe Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
  114. 8.19.5 Beijing Xiehe Pharmaceutical Recent Developments
  115. 8.20 Baxter
  116. 8.20.1 Baxter Company Information
  117. 8.20.2 Baxter Business Overview
  118. 8.20.3 Baxter Pemetrexed Disodium Lyophilized Powder Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Baxter Pemetrexed Disodium Lyophilized Powder Product Portfolio
  120. 8.20.5 Baxter Recent Developments
  121. 8.21 Zydus Lifesciences
  122. 8.21.1 Zydus Lifesciences Company Information
  123. 8.21.2 Zydus Lifesciences Business Overview
  124. 8.21.3 Zydus Lifesciences Pemetrexed Disodium Lyophilized Powder Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 Zydus Lifesciences Pemetrexed Disodium Lyophilized Powder Product Portfolio
  126. 8.21.5 Zydus Lifesciences Recent Developments
  127. 8.22 Waverley Pharma
  128. 8.22.1 Waverley Pharma Company Information
  129. 8.22.2 Waverley Pharma Business Overview
  130. 8.22.3 Waverley Pharma Pemetrexed Disodium Lyophilized Powder Sales, Value and Gross Margin (2021-2026)
  131. 8.22.4 Waverley Pharma Pemetrexed Disodium Lyophilized Powder Product Portfolio
  132. 8.22.5 Waverley Pharma Recent Developments
  133. 8.23 Pfizer (Hospira)
  134. 8.23.1 Pfizer (Hospira) Company Information
  135. 8.23.2 Pfizer (Hospira) Business Overview
  136. 8.23.3 Pfizer (Hospira) Pemetrexed Disodium Lyophilized Powder Sales, Value and Gross Margin (2021-2026)
  137. 8.23.4 Pfizer (Hospira) Pemetrexed Disodium Lyophilized Powder Product Portfolio
  138. 8.23.5 Pfizer (Hospira) Recent Developments
  139. 8.24 Nang Kuang Pharmaceutical
  140. 8.24.1 Nang Kuang Pharmaceutical Company Information
  141. 8.24.2 Nang Kuang Pharmaceutical Business Overview
  142. 8.24.3 Nang Kuang Pharmaceutical Pemetrexed Disodium Lyophilized Powder Sales, Value and Gross Margin (2021-2026)
  143. 8.24.4 Nang Kuang Pharmaceutical Pemetrexed Disodium Lyophilized Powder Product Portfolio
  144. 8.24.5 Nang Kuang Pharmaceutical Recent Developments
  145. 8.25 Eugia Pharma
  146. 8.25.1 Eugia Pharma Company Information
  147. 8.25.2 Eugia Pharma Business Overview
  148. 8.25.3 Eugia Pharma Pemetrexed Disodium Lyophilized Powder Sales, Value and Gross Margin (2021-2026)
  149. 8.25.4 Eugia Pharma Pemetrexed Disodium Lyophilized Powder Product Portfolio
  150. 8.25.5 Eugia Pharma Recent Developments
  151. 8.26 Dr. Reddy's Laboratories
  152. 8.26.1 Dr. Reddy's Laboratories Company Information
  153. 8.26.2 Dr. Reddy's Laboratories Business Overview
  154. 8.26.3 Dr. Reddy's Laboratories Pemetrexed Disodium Lyophilized Powder Sales, Value and Gross Margin (2021-2026)
  155. 8.26.4 Dr. Reddy's Laboratories Pemetrexed Disodium Lyophilized Powder Product Portfolio
  156. 8.26.5 Dr. Reddy's Laboratories Recent Developments
  157. 8.27 Biocon
  158. 8.27.1 Biocon Company Information
  159. 8.27.2 Biocon Business Overview
  160. 8.27.3 Biocon Pemetrexed Disodium Lyophilized Powder Sales, Value and Gross Margin (2021-2026)
  161. 8.27.4 Biocon Pemetrexed Disodium Lyophilized Powder Product Portfolio
  162. 8.27.5 Biocon Recent Developments
  163. 8.28 APOTEX
  164. 8.28.1 APOTEX Company Information
  165. 8.28.2 APOTEX Business Overview
  166. 8.28.3 APOTEX Pemetrexed Disodium Lyophilized Powder Sales, Value and Gross Margin (2021-2026)
  167. 8.28.4 APOTEX Pemetrexed Disodium Lyophilized Powder Product Portfolio
  168. 8.28.5 APOTEX Recent Developments
  169. 8.29 Amneal Pharmaceuticals
  170. 8.29.1 Amneal Pharmaceuticals Company Information
  171. 8.29.2 Amneal Pharmaceuticals Business Overview
  172. 8.29.3 Amneal Pharmaceuticals Pemetrexed Disodium Lyophilized Powder Sales, Value and Gross Margin (2021-2026)
  173. 8.29.4 Amneal Pharmaceuticals Pemetrexed Disodium Lyophilized Powder Product Portfolio
  174. 8.29.5 Amneal Pharmaceuticals Recent Developments
  175. 8.30 Accord Healthcare
  176. 8.30.1 Accord Healthcare Company Information
  177. 8.30.2 Accord Healthcare Business Overview
  178. 8.30.3 Accord Healthcare Pemetrexed Disodium Lyophilized Powder Sales, Value and Gross Margin (2021-2026)
  179. 8.30.4 Accord Healthcare Pemetrexed Disodium Lyophilized Powder Product Portfolio
  180. 8.30.5 Accord Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pemetrexed Disodium Lyophilized Powder Value Chain Analysis
  2. 9.1.1 Pemetrexed Disodium Lyophilized Powder Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pemetrexed Disodium Lyophilized Powder Sales Mode & Process
  6. 9.2 Pemetrexed Disodium Lyophilized Powder Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pemetrexed Disodium Lyophilized Powder Distributors
  9. 9.2.3 Pemetrexed Disodium Lyophilized Powder Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst